| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $65.8M | — | +40.5% |
| Cost of Revenue | $32.1M | — | -17.9% |
| Gross Profit | $33.7M | — | +336.3% |
| R&D Expense | $3.9M | — | -20.4% |
| SG&A Expense | $29.1M | — | -26.5% |
| Operating Income | -$2.2M | — | +95.6% |
| Pre-tax Income | -$6.5M | — | +87.6% |
| Income Tax | -$151K | — | -193.2% |
| Net Income | -$3.7M | — | +87.5% |
| EPS (Basic) | -$0.02 | — | +90.5% |
| EPS (Diluted) | -$0.02 | — | +90.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $165.9M | -23.5% | -41.8% |
| Accounts Receivable | $33.4M | +31.0% | +17.3% |
| Inventory | $40.5M | -0.1% | -18.7% |
| Current Assets | $251.7M | -15.0% | -33.1% |
| Total Assets | $713.2M | -7.4% | -25.7% |
| Current Liabilities | $42.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.7M | — | +192.3% |
| Capital Expenditures | $4.4M | — | -15.2% |
| Investing Cash Flow | -$4.4M | — | +80.8% |
| Financing Cash Flow | -$55.2M | — | -1027.1% |
| Free Cash Flow | $4.2M | — | +128.9% |
| -32.5% |
| Long-term Debt | $241.0M | -17.4% | -18.3% |
| Total Liabilities | $344.1M | -13.5% | -19.9% |
| Stockholders' Equity | $211.6M | -0.4% | -29.6% |